Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasm, Residual × Interferon alpha-2 × Clear all

Sponsor

Conditions

Melanoma 12 Carcinoma, Renal Cell 10 Lymphoma 3 Neoplasms 2 Colorectal Neoplasms 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Polycythemia Vera 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Margins of Excision 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Kidney Neoplasms 1 Hodgkin Disease 1 Hematologic Neoplasms 1 HTLV-I Infections 1 Carcinoma 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1 Adenocarcinoma 1

Interventions

Rituximab 4 blinatumomab 3 Whole-Body Irradiation 2 Lenalidomide 2 Cyclophosphamide 2 Clofarabine 2 treosulfan 1 thymoglobulin 1 sabatolimab 1 peginterferon alfa-2a 1 obinutuzumab 1 midostaurin 1 ixazomib 1 fludarabine phosphate 1 fludarabine 1 eribulin 1 daratumumab 1 acalabrutinib 1 Trastuzumab 1 Tacrolimus 1 Sodium Chloride 1 Peripheral Blood Stem Cell Transplantation 1 Pentostatin 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Magnetic Resonance Imaging 1 Imatinib Mesylate 1 Histamine Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡